Business Segments · Identifiable assets
Life Sciences — Identifiable assets
Danaher Life Sciences — Identifiable assets decreased by 0.4% to $23.11B in Q4 2025 compared to the prior quarter.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityStable
First reportedQ4 2023
Last reportedQ4 2025
Rolls up toTotal Assets
How to read this metric
Growth in assets without corresponding growth in income may suggest declining capital efficiency.
Detailed definition
The total value of assets that can be specifically attributed to the Life Sciences segment, including inventory, propert...
Peer comparison
Comparable to segment asset reporting for diversified industrial and life science conglomerates.
Metric ID:
dhr_segment_life_sciences_identifiable_assetsHistorical Data
3 periods
| Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|
| Value | $23.73B | $23.21B | $23.11B |
| QoQ Change | — | -2.2% | -0.4% |
| YoY Change | — | -2.2% | -0.4% |
Range$23.11B – $23.73B
Avg YoY Growth-1.3%
Median YoY Growth-1.3%
Current Streak2+ quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Danaher's life sciences — identifiable assets?
- Danaher (DHR) reported life sciences — identifiable assets of $23.11B in Q4 2025.
- What does life sciences — identifiable assets mean?
- The total value of assets specifically assigned to the Life Sciences business unit.